| Disclosure of detailed information about income tax provision [text block] |
| |
|
Year ended March 31, 2026 |
|
|
Year ended March 31, 2025 |
|
|
Year ended March 31, 2024 |
|
| Income (loss) before taxes for the year |
|
$ |
(6,898,108 |
) |
|
$ |
(3,615,375 |
) |
|
$ |
(4,472,170 |
) |
| Canadian federal and provincial income tax rates |
|
|
27 |
% |
|
|
27 |
% |
|
|
27 |
% |
| Expected income tax recovery based on above rates |
|
|
(1,862,000 |
) |
|
|
(976,000 |
) |
|
|
(1,207,000 |
) |
| Change in statutory, foreign tax, foreign exchange rates and other |
|
|
- |
|
|
|
35,000 |
|
|
|
(3,000 |
) |
| Permanent difference |
|
|
459,000 |
|
|
|
214,000 |
|
|
|
204,000 |
) |
| Impact of spin-out transaction |
|
|
(129,000 |
) |
|
|
(527,000 |
) |
|
|
- |
|
| Impact of flow-through shares |
|
|
1,462,000 |
|
|
|
130,000 |
|
|
|
124,000 |
|
| Share issue costs |
|
|
(319,000 |
) |
|
|
(182,000 |
) |
|
|
(129,000 |
) |
| Adjustment to prior year’s provision versus statutory tax returns and expiry of non-capital losses |
|
|
1,234,000 |
|
|
|
330,000 |
|
|
|
(94,000 |
) |
| Change in unrecognized deductible temporary differences |
|
|
(845,000 |
) |
|
|
976,000 |
|
|
|
1,105,000 |
|
| Deferred income tax recovery |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
| Disclosure of deferred taxes [text block] |
| |
|
Year ended March 31, 2026 |
|
|
Year ended March 31, 2025 |
|
| Deferred tax assets (liabilities) |
|
|
|
|
|
|
|
|
| Exploration and evaluation assets |
|
$ |
(4,448,000 |
) |
|
$ |
(1,257,000 |
) |
| Marketable securities |
|
|
(104,000 |
) |
|
|
- |
|
| Non-capital losses |
|
|
4,552,000 |
|
|
|
1,257,000 |
|
| |
|
$ |
- |
|
|
$ |
- |
|
|
| Disclosure of temporary difference, unused tax losses and unused tax credits [text block] |
| |
|
Year ended March 31, 2026 |
|
|
Expiry date range year ended
March 31, 2026 |
|
|
Year ended March 31, 2025 |
|
|
Expiry date range year ended
March 31, 2025 |
|
| Temporary differences |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issue costs |
|
$ |
1,562,000 |
|
|
2046 to 2049 |
|
|
|
869,000 |
|
|
$ |
2046 to 2049 |
|
| Other |
|
|
97,000 |
|
|
No expiry date |
|
|
|
- |
|
|
No expiry date |
|
| Investment in associate |
|
|
- |
|
|
No expiry date |
|
|
|
106,000 |
|
|
No expiry date |
|
| Allowable capital losses |
|
|
- |
|
|
No expiry date |
|
|
|
- |
|
|
No expiry date |
|
| Net operating losses available for future period |
|
|
- |
|
|
No expiry date |
|
|
|
- |
|
|
No expiry date |
|
| Non-capital losses available for future period |
|
|
10,928,000 |
|
|
2031 to 2046 |
|
|
|
15,182,000 |
|
|
|
2031 to 2045 |
|
| Canada |
|
|
12,459,000 |
|
|
2031 to 2046 |
|
|
|
19,837,000 |
|
|
|
2031 to 2045 |
|
| USA |
|
|
- |
|
|
No expiry date |
|
|
|
- |
|
|
No expiry date |
|
|